Capsule impedes adhesion to and invasion of epithelial cells by Klebsiella pneumoniae

Infection and Immunity

Volumn 68, Issue 12, 2000, Pages 6744-6749

  Sahly, Hany ^a,d   Podschun, Rainer ^a   Oelschlaeger, Tobias A ^b   Greiwe, Michael ^a   Parolis, Haralambos ^e   Hasty, David ^f   Kekow, JÖRN ^c   Ullmann, Uwe ^a   Ofek, Itzhak ^d   Sela, Shlomo ^d  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d TEL AVIV UNIVERSITY   (Israel)

^e RHODES UNIVERSITY   (South Africa)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL MEMBRANE; BACTERIUM ADHERENCE; BLADDER EPITHELIUM; CONTROLLED STUDY; FIMBRIA; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; INTERNALIZATION; INTESTINE EPITHELIUM CELL; KLEBSIELLA PNEUMONIAE; PRIORITY JOURNAL;

BACTERIAL ADHESION; BACTERIAL CAPSULES; CELL LINE; EPITHELIAL CELLS; HUMANS; INTESTINAL MUCOSA; KLEBSIELLA PNEUMONIAE; URINARY BLADDER;

EID: 0034440538     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.12.6744-6749.2000     Document Type: Article

References (41)

1. Blumenkrantz, N., and G. Asboe-Hansen. 1973. New method for quantitative determination of uronic acids. Anal. Biochem. 54:484-489.
2. Campbell, W., E. Hendrix, S. J. Cryz, and A. Cross. 1996. Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma. Clin. Infect. Dis. 23:179-181.
3. Casewell, M., and H. G. Talsania. 1979. Predominance of certain Klebsiella capsular types in hospitals in the United Kingdom. J. Infect. 1:77-79.
4. Cryz, S. J., E. Fürer, and R. Germanier. 1984. Experimental Klebsiella pneumoniae burn wound sepsis: role of capsular polysaccharide. Infect. Immun. 43:440-441.
5. Cryz, S. J., Jr., E. Fürer, and R. Germanier. 1985. Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans. J. Infect. Dis. 151:665-671.
6. Cryz, S. J., P. M. Mortimer, V. Mansfield, and R. Germanier. 1986. Sero-epidemiology of Klebsiella bacteremic isolates and implications for vaccine development. J. Clin. Microbiol. 23:687-690.
7. De Champ, C., M. P. Sauvant, C. Chanal, D. Sirot, N. Gazuy, R. Malhuret, J. C. Baguet, and J. Sirot. 1989. Prospective survey of colonization and infection caused by extended spectrum-beta-lactamase-producing members of the family Enterobacteriaceae in intensive care units. J Clin. Microbiol. 27:2887-2890.
8. De Vries, F. P., A. van der Ende, J. P. M. van Putten, and J. Dankert. 1996. Invasion of primary nasopharyngeal epithelial cells by Neisseria meningitidis is controlled by phase variation of multiple surface antigens. Infect. Immun. 64:2998-3006.
9. Domenico, P., W. G. Johanson, and D. C. Straus. 1982. Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae. Infect. Immun. 37:327-335.
10. Domenico, P., D. R. Landolphi, and B. A. Cunha. 1991. Reduction of capsular polysaccharide and potentiation of aminoglycoside inhibition in Gram-negative bacteria by bismuth salicylate. J. Antimicrob. Chemother. 28:801-810.
11. Domenico, P., S. Schwartz, and B. A. Cunha. 1989. Reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate. Infect. Immun. 57:3778-3782.
12. Domenico, P., J. M. Tomas, S. Merino, X. Rubires, and B. A. Cunha. 1999. Surface antigen exposure by bismuth dimercaprol suppression of Klebsiella pneumoniae capsular polysaccharide. Infect. Immun. 67:664-669.
13. Donnenberg, M. S. 1999. Interactions between enteropathogenic Escherichia coli and epithelial cells. Clin. Infect. Dis. 28:451-455.
14. Donnenberg, M. S., J. K. Kaper, and B. Finlay. 1997. Interaction between enteropathogenic Escherichia coli and host epithelial cells. Trends Microbiol. 5:109-114.
15. Dutton, G. G. S., S. K. Ng, L. A. S. Parolis, and H. Parolis. 1989. A re-investigation of the structure of the capsular polysaccharides of Klebsiella K10. Carbohydr. Res. 193:147-155.
16. Edelman, R., D. N. Taylor, S. S. Wasserman, J. B. McClain, A. S. Cross, J. C. Sadoff, J. U. Que, and S. J. Cryz. 1994. Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously. Vaccine 12:1288-1294.
17. Ehrenwort, L., and H. Baer. 1956. The pathogenicity of Klebsiella pneumoniae for mice: the relationship to the quantity and rate of production of type-specific capsular polysaccharide. J. Bacteriol. 72:713-717.
18. Falkow, S. 1997. Perspectives series: host/pathogen interactions. Invasion and intracellular sorting of bacteria: searching for bacterial genes expressed during host/pathogen interactions. J. Clin. Investig. 100:239-243.
19. Favre-Bonte, S., B. Joly, and C. Forestier. 1999. Consequences of reduction of Klebsiella pneumoniae capsule expression on interaction of this bacterium with epithelial cells. Infect. Immun. 67:554-561.
20. Fumagalli, O., B. Tall, C. Schipper, and T. A. Oelschlaeger. 1997. N-glycosylated proteins are involved in efficient internalization of Klebsiella pneumoniae by cultured human epithelial cells. Infect. Immun. 65:4445-4451.
21. Highsmith, A. K., and W. R. Jarvis. 1985. Klebsiella pneumoniae: selected virulence factors that contribute to pathogenicity. Infect. Control 6:75-77.
22. Matatov, R., I. Ofek, E. Skutelsky, I. Schechter, R. Perry, R. Podschun, H. Sahly, K. Thankavel, S. N. Abraham, and J. Goldhar. 1999. Inability of encapsulated Klebsiella pneumoniae to assemble functional type 1 fimbriae on their surface. FEMS Microbiol. Lett. 179:123-130.
23. Neeman, R., N. Keller, A. Brazilai, Z. Korenman, and S. Sela. 1998. Prevention of internalisation-associated gene, prtF1, among persisting group-A Streptococcus strains isolated from asymptomatic carriers. Lancet 352:1974-1977.
24. Oelschlaeger, T., and B. Tall. 1997. Invasion of cultured human epithelial cells by Klebsiella pneumoniae isolated from the urinary tract. Infect. Immun. 65:2950-2958.
25. Ofek, I., J. Goldhar, Y. Keisari, and N. Sharon. 1995. Nonopsonic phagocytosis of microorganisms. Annu. Rev. Microbiol. 49:239-276.
26. Ofek, I., K. Kabha, A. Athamna, G. Frankel, D. J. Wozniak, L. D. Hasty, and E. D. Ohman. 1993. Genetic exchange of determinants for capsular polysaccharide biosynthesis between Klebsiella pneumoniae strains expressing serotypes K2 and K21a. Infect. Immun. 61:4208-4216.
27. Ørskov, I., and M. A. Fife-Asbury. 1979. New Klebsiella capsular antigen, K82, and the deletion of five of those previously assigned. Int. J. Syst. Bacteriol. 27:386-387.
28. Podschun, R. 1990. Phenotypic properties of Klebsiella pneumoniae and K. oxytoca isolated from different sources. Zentbl. Hyg. 189:527-535.
29. Podschun, R., P. Heineken, U. Ullmann, and H. G. Sonntag. 1986. Comparative investigations of Klebsiella species of clinical origin: plasmid patterns, biochemical reactions, antibiotic resistances and serotypes. Zentbl. Bakteriol. Hyg. A 262:335-345.
30. Podschun, R., I. Penner, and U. Ullmann. 1992. Interaction of Klebsiella capsular type 7 with human polymorphonuclear leucocytes. Microb. Pathog. 13:371-379.
31. Podschun, R., and H. Sahly. 1991. Hemagglutinins of Klebsiella pneumoniae and Klebsiella oxytoca isolated from different sources. Zentbl. Hyg. 191:46-52.
32. Podschun, R., and U. Ullmann. 1993. Bacteriocin typing of environmental Klebsiella isolates. Zentbl. Hyg. 195:22-26.
33. Podschun, R., and U. Ullmann. 1992. Klebsiella capsular type K7 in relation to toxicity, susceptibility to phagocytosis and resistance to serum. J. Med. Microbiol. 36:250-254.
34. Podschun, R., and U. Ullmann. 1998. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 11:589-603.
35. Riser, E., and P. Noone. 1981. Klebsiella capsular type versus site of isolation. J. Clin. Pathol. 34:552-555.
36. Sahly, H., and R. Podschun. 1997. Clinical, bacteriological, and serological aspects of Klebsiella infections and their spondylarthopathic sequelae. Clin. Diagn. Lab. Immunol. 4:393-399.
37. Sahly, H., R. Podschun, R. Sass, B. Bröcker, W. L. Gross, J. Kekow, and U. Ullmann. 1994. Serum antibodies to the 77 Klebsiella capsular types in ankylosing spondylitis. Arthritis Rheum. 37:754-759.
38. Simoons-Smit, A. M., A. M. J. J. Verweij-van Vught, I. Y. R. Kanis, and D. M. MacLaren. 1985. Chemiluminescence of human leucocytes stimulated by clinical isolates of Klebsiella. J. Med. Microbiol. 19:333-338.
39. Simoons-Smit, A. M., A. M. J. J. Verweij-van Vught, and D. M. MacLaren. 1986. The role of K antigens as virulence factors in Klebsiella. J. Med. Microbiol. 21:133-137.
40. Weller, T. M. A., F. M. Mackenzie, and K. J. Forbes. 1997. Molecular epidemiology of a large outbreak of multiresistant Klebsiella pneumoniae. J. Med. Microbiol. 46:921-926.
41. Williams, P., P. A. Lambert, M. R. W. Brown, and R. J. Jones. 1983. The role of the O and K antigens in determining the resistance of Klebsiella aerogenes to serum killing and phagocytosis. J. Gen. Microbiol. 129:2181-2191.